NCT00021216View on ClinicalTrials.gov

Bortezomib in Treating Children With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

91006-3776

Children's Oncology Group, Arcadia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00021216 - Bortezomib in Treating Children With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter